In light of the fact that 70–80% patients who succumb to sepsis harbor persistent, chronic, ongoing, or secondary infections (13), G-CSF or GM-CSF combined with other immune regulators may bolster immune response and eradicate infection in septic T2D populations, potentially improving overall survival (254, 261). This evidence concerns the gene CSF2 and infection.